[{"NetIncomeLoss_1_Q2_USD":-7898000.0,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":8000.0,"LongTermDebt_0_Q2_USD":46081000.0,"AssetsCurrent_0_Q2_USD":141795000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":19839000.0,"FinanceLeaseInterestPaymentOnLiability_2_Q2_USD":1000.0,"PaymentsToAcquireInvestments_2_Q2_USD":23966000.0,"Depreciation_1_Q2_USD":633000.0,"Depreciation_2_Q2_USD":1405000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-3287000.0,"InterestPaidNet_2_Q2_USD":739000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":9288000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"GeneralAndAdministrativeExpense_1_Q2_USD":8669000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":17032000.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":-65000.0,"DerivativeGainLossOnDerivativeNet_2_Q2_USD":-105000.0,"Liabilities_0_Q2_USD":91829000.0,"DerivativeGainLossOnDerivativeNet_1_Q2_USD":-84000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":12264000.0,"CashUninsuredAmount_0_Q2_USD":52578000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":15272000.0,"ShareBasedCompensation_2_Q2_USD":6499000.0,"UnrealizedGainLossOnInvestments_2_Q2_USD":-31000.0,"Assets_0_Q2_USD":210532000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":482000.0,"CommonStockSharesIssued_0_Q2_shares":41337108.0,"AccountsReceivableBilledForLongTermContractsOrPrograms_0_Q2_USD":18182000.0,"OperatingLeaseLeaseIncomeLeasePayments_2_Q2_USD":822000.0,"FinanceLeaseInterestExpense_1_Q2_USD":0.0,"FinanceLeaseInterestExpense_2_Q2_USD":0.0,"AccruedSalariesCurrent_0_Q2_USD":7638000.0,"SellingAndMarketingExpense_1_Q2_USD":19250000.0,"SellingAndMarketingExpense_2_Q2_USD":37224000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":7092000.0,"ProceedsFromIssuanceOfLongTermDebt_2_Q2_USD":15000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":336495000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":53078000.0,"Revenues_2_Q2_USD":64617000.0,"CommonStockValue_0_Q2_USD":413000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.5891,"AccountsReceivableNetCurrent_0_Q2_USD":18182000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-124000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-132000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":41080898.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":40894405.0,"FinanceLeasePrincipalPayments_2_Q2_USD":8000.0,"InventoryWriteDown_2_Q2_USD":2455000.0,"EarningsPerShareBasic_2_Q2_USD":-0.36,"EarningsPerShareBasic_1_Q2_USD":-0.19,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":980000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":5723000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":11471000.0,"Revenues_1_Q2_USD":33580000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":20337000.0,"InvestmentIncomeNet_2_Q2_USD":63000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-5061000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.0103,"AmortizationOfIntangibleAssets_1_Q2_USD":49000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":96000.0,"IncreaseDecreaseInInventories_2_Q2_USD":3341000.0,"OtherPrepaidExpenseCurrent_0_Q2_USD":835000.0,"ProceedsFromIssuanceOfDebt_2_Q2_USD":0.0,"RestrictedCash_0_Q2_USD":6333000.0,"DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_0_Q2_USD":3919000.0,"CostsAndExpenses_1_Q2_USD":33642000.0,"CostsAndExpenses_2_Q2_USD":65727000.0,"StockIssuedDuringPeriodValueOther_1_Q2_USD":0.0,"StockIssuedDuringPeriodValueOther_2_Q2_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":18604000.0,"NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_2_Q2_USD":190000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q2_USD":3440000.0,"InvestmentIncomeNet_1_Q2_USD":29000.0,"ShortTermInvestments_0_Q2_USD":46839000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-199000.0,"OperatingIncomeLoss_2_Q2_USD":-13374000.0,"InterestExpense_1_Q2_USD":565000.0,"InterestExpense_2_Q2_USD":1010000.0,"NonoperatingIncomeExpense_1_Q2_USD":-744000.0,"NonoperatingIncomeExpense_2_Q2_USD":-1184000.0,"PaymentsOfDebtIssuanceCosts_2_Q2_USD":0.0,"AccountsPayableCurrent_0_Q2_USD":6721000.0,"LiabilitiesCurrent_0_Q2_USD":21628000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":41080898.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":40894405.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_2_Q2_USD":32295000.0,"RepaymentsOfDebt_2_Q2_USD":0.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":3645000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-11515000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":6499000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3804000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":59411000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3948000.0,"LongTermDebtNoncurrent_0_Q2_USD":46081000.0,"NetIncomeLoss_2_Q2_USD":-14558000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":50952000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":3035000.0,"PrepaidInsurance_0_Q2_USD":1389000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":2108000.0,"PaymentsToAcquireIntangibleAssets_2_Q2_USD":692000.0,"ShortTermLeaseCost_1_Q2_USD":6000.0,"ShortTermLeaseCost_2_Q2_USD":11000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.1017,"FinanceLeaseRightOfUseAssetAmortization_2_Q2_USD":8000.0,"FinanceLeaseRightOfUseAssetAmortization_1_Q2_USD":2000.0,"GrossProfit_1_Q2_USD":26488000.0,"GrossProfit_2_Q2_USD":52353000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":2460000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":5480000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":3612000.0,"CommonStockSharesAuthorized_0_Q2_shares":100000000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0728,"AmortizationOfFinancingCosts_2_Q2_USD":227000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":57182000.0,"DerivativeLiabilitiesNoncurrent_0_Q2_USD":3776000.0,"FinanceLeaseRightOfUseAsset_0_Q2_USD":53000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":3805000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":6499000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":210532000.0,"OperatingLeaseCost_2_Q2_USD":2081000.0,"OperatingLeaseCost_1_Q2_USD":1034000.0,"PrepaidAdvertising_0_Q2_USD":270000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":3088000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":14000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"StockRepurchasedDuringPeriodValue_2_Q2_USD":0.0,"InventoryNet_0_Q2_USD":13415000.0,"OperatingIncomeLoss_1_Q2_USD":-7154000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1775000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":6230000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_2_Q2_USD":371000.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":14000.0,"EarningsPerShareDiluted_1_Q2_USD":-0.19,"EarningsPerShareDiluted_2_Q2_USD":-0.36,"CommonStockSharesOutstanding_0_Q2_shares":41337108.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":498000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":3802000.0,"LeaseCost_1_Q2_USD":1211000.0,"LeaseCost_2_Q2_USD":2437000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-218205000.0,"VariableLeaseCost_2_Q2_USD":337000.0,"VariableLeaseCost_1_Q2_USD":169000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":258000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":10924000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":0.0,"InsuranceReceivableForMalpracticeCurrent_0_Q2_USD":23000.0,"StockholdersEquity_0_Q2_USD":118703000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":0.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-3000.0,"Ticker":"AXGN","CIK":"805928","name":"AXOGEN, INC.","OfficialName":"Axogen Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"313567338.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]